Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Irina U. Agoulnik et al.|The FASEB Journal|2019Cited by 35
Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profileKenneth J. Wilson, Juan Marugán, Jingbo Xiao et al.|European Journal of Medicinal Chemistry|2018Cited by 17
Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2María Esteban-López, Alexander I. Agoulnik, Kenneth J. Wilson et al.|Communications Biology|2022Cited by 9
Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral ObstructionHooi Hooi Ng, Alexander I. Agoulnik, Mariluz Soula et al.|Frontiers in Physiology|2021Cited by 2
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Hooi Hooi Ng et al.|Endocrine Abstracts|2019Cited by 1